Amarin Moves Beyond Bridge Financing With $70 Million Private Placement

Existing and new investors are drawn by the potential of a compound that would compete with statins in the dyslipidemia market.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet